CD160

gene product
BY55, NK1, NK28
CD160 is an 27 kDa glycoprotein which was initially identified with the monoclonal antibody BY55. Its expression is tightly associated with peripheral blood NK cells and CD8 T lymphocytes with cytolytic effector activity. The cDNA sequence of CD160 predicts a cysteine-rich, glycosylphosphatidylinositol-anchored protein of 181 amino acids with a single Ig-like domain weakly homologous to KIR2DL4 molecule. CD160 is expressed at the cell surface as a tightly disulfide-linked multimer. RNA blot analysis revealed CD160 mRNAs of 1.5 and 1.6 kb whose expression was highly restricted to circulating NK and T cells, spleen and small intestine. Within NK cells CD160 is expressed by CD56dimCD16+ cells whereas among circulating T cells its expression is mainly restricted to TCRgd bearing cells and to TCRab+CD8brightCD95+CD56+CD28-CD27-cells. In tissues, CD160 is expressed on all intestinal intraepithelial lymphocytes. CD160 shows a broad specificity for binding to both classical and nonclassical MHC class I molecules. [provided by RefSeq, Jul 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Reference

Provider

Host

Reactivity

Antibody type

  or   Clear
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
60 antibodies from 11 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeWBELIFIPIHFC
antibodies-online
18 antibodies
Abnova Corporation
5 antibodies
Novus Biologicals
9 antibodies
Aviva Systems Biology
5 antibodies
Creative Biomart
6 antibodies
GeneTex
4 antibodies
Acris Antibodies GmbH
2 antibodies
Thermo Fisher Scientific Pierce
1 antibody
BioLegend
7 antibodies
Sigma-Aldrich
2 antibodies
LifeSpan BioSciences, Inc.
1 antibody